These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2907704)

  • 1. Studies on the optimal conditions for inactivation of Bordetella pertussis organisms with glutaraldehyde for preparation of a safe and potent pertussis vaccine.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Vaccine; 1988 Dec; 6(6):491-6. PubMed ID: 2907704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of glutaraldehyde inactivated pertussis vaccine.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Vaccine; 1990 Dec; 8(6):563-8. PubMed ID: 2128428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of elevated temperatures on the opacity and toxicity of pertussis vaccines manufactured with different inactivating agents.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    Vaccine; 1986 Sep; 4(3):185-90. PubMed ID: 3094265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The detoxification of Bordetella pertussis with glutaraldehyde.
    Iida T; Horiuchi Y
    J Biol Stand; 1987 Jan; 15(1):17-26. PubMed ID: 2881932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutaraldehyde in whole-cell Bordetella pertussis vaccine.
    Arya SC; Ashraf SJ; Pathak VP
    Vaccine; 1989 Dec; 7(6):486. PubMed ID: 2514517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of a safe, potent and immunogenic partially purified acellular pertussis vaccine using simple indigenous techniques.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Dev Biol Stand; 1991; 73():205-22. PubMed ID: 1778314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of different inactivating agents on the potency, toxicity and stability of pertussis vaccine.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1987 Jan; 15(1):87-98. PubMed ID: 3104344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutaraldehyde inactivated pertussis vaccine: a less histamine sensitizing vaccine.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1987 Apr; 15(2):159-64. PubMed ID: 3110164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between mouse intracerebral potency & 50 per cent histamine sensitizing dose of pertussis vaccine.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    Indian J Med Res; 1989 May; 89():144-9. PubMed ID: 2476391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutaraldehyde inactivated pertussis vaccine: a safe vaccine in the innocuity test.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    Vaccine; 1987 Jun; 5(2):102-4. PubMed ID: 2440196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative stabilities of glutaraldehyde & heat inactivated pertussis vaccine components of adsorbed DPT vaccine with different preservatives.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Indian J Med Res; 1992 Jan; 95():8-11. PubMed ID: 1577522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pertussis antigens--screening models on toxicity.
    Ronneberger H; Blackkolb F; Guthöhrlein G
    Arch Toxicol Suppl; 1982; 5():129-32. PubMed ID: 6285854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and biological properties of solubilized envelope proteins of Bordetella pertussis.
    Robinson A; Hawkins DC
    Infect Immun; 1983 Feb; 39(2):590-8. PubMed ID: 6299946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assay of pertussis vaccine reactivity factors by measurement of the paw swelling response, endotoxin and histamine-sensitizing factor.
    Vuolo AM; Lustigman B
    Biologicals; 1993 Mar; 21(1):45-52. PubMed ID: 8217117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on Toxicity Reduction and Potency Induction in Whole-cell Pertussis Vaccine by Developing a New Optimal Inactivation Condition Processed on Bordetella pertussis.
    Mohammadpour Dounighi N; Razzaghi-Abyane M; Nofeli M; Zolfagharian H; Shahcheraghi F
    Jundishapur J Microbiol; 2016 Jul; 9(7):e34153. PubMed ID: 27679704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detoxification of Bordetella pertussis organisms or pertussis toxin with glutaraldehyde for preparation of pertussis vaccine.
    Gupta RK
    Vaccine; 1991 Sep; 9(9):690-1. PubMed ID: 1950101
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative biological activities of whole cell pertussis vaccine and a new acellular preparation.
    García-Sánz JA; Ruiz-Puente J; Jiménez-Paredes J; González-Pacheco M; Villalva-Posada H
    Vaccine; 1985 Mar; 3(1):23-6. PubMed ID: 4039870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-Mediated and Humoral Immune Responses to Bordetella pertussis Inactivated Whole-Cells Encapsulated Alginate Microspheres as a New Vaccine Candidate.
    Dounighi NM; Shahcheraghi F; Razzaghi-Abyaneh M; Nofeli M; Zolfagharian H
    Curr Pharm Biotechnol; 2017; 18(7):585-593. PubMed ID: 28814229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Vaccine Delivery Vehicle and Adjuvant Candidate: Bordetella pertussis Inactivated Whole Cells Entrapped in Alginate Microspheres.
    Dounighi NM; Shahcheraghi F; Razzaghi-Abyaneh M; Nofeli M; Zolfagharian H
    Curr Pharm Des; 2017; 23(18):2665-2672. PubMed ID: 28079006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetone-treated pertussis vaccine--a potent and safer new pertussis vaccine.
    Saran G
    J Biol Stand; 1985 Oct; 13(4):315-20. PubMed ID: 4055808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.